期刊文献+

木丹颗粒对实验性大鼠糖尿病周围神经病变的疗效研究 被引量:16

Efficacy of Mu Dan granules on experimental rats with diabetic peripheral neuropathy
原文传递
导出
摘要 目的研究木丹颗粒对糖尿病周围神经病变(DPN)的作用疗效。方法采用STZ腹腔注射法制备DPN大鼠动物模型,分为模型+木丹颗粒(Ⅳ)组、模型+甲钴胺(Ⅲ)组,模型(Ⅱ)组和对照(Ⅰ)组,分别灌胃给药,观察木丹颗粒对DPN指标的影响。结果与Ⅱ组相比,Ⅳ组血糖下降,体重增加,差异无统计学意义(P>0.05),神经传导速度增快(P<0.01),足迹步态参数足印长(PL)、足印宽(TS)、足中间三指宽(ITS)改善(P<0.01);与Ⅲ组相比,Ⅳ组血糖水平,体重水平,差异无统计学意义(P>0.05),神经传导速度增快(P<0.01),足迹步态参数PL改善(P<0.01),TS、ITS差异无统计学意义。Ⅳ组表皮内神经纤维的数量与形态及周围神经的病理损害得到改善,其改善作用优于甲钴胺。结论木丹颗粒可改善糖尿病大鼠的周围神经病变指标,其作用效果优于甲钴胺。 Objective To investigate the efficacy of Mu Dan granules on diabetic peripheral neuropathy in experimental rats. Methods Rat models of diabetic peripheral neuropathy(DPN)were induced by intraperitoneal injection of STZ.All experimental rats were divided into 4groups:model+Mu Dan granules group(groupⅣ,n=10),model+mecobalamin group(groupⅢ,n=10),model group(groupⅡ,n=9)and normal group(group I,n=10).Drugs were given by intragastric administration. ResultsCompared with groupⅡ,blood glucose decreased and body weight increased in groupⅣ,but the difference was not statistically significant(P〉0.05);nerve conduction velocity increased(P〈0.01);footprint gait parameters including PL,TS and ITS were improved(P〈0.01).Compared with groupⅢ,the changes of blood glucose level and body weight in group Ⅳ were not statistically significant(P〉0.05);nerve conduction velocity increased in groupⅣ(P〈0.01);PL was improved(P〈0.01),but the differences of TS and ITS were not statistically significant;quantity and morphology of nerve fibers in the skin and pathological damage of peripheral nerve were significantly improved in group Ⅳ,suggesting Mu Dan granules' superiority to mecobalamin. Conclusion Mu Dan granules can significantly improve diabetic peripheral neuropathy in rats and is superior to mecobalamin.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第12期1099-1102,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金(81173424 81373796)
关键词 木丹颗粒 糖尿病周围神经病变 动物实验 Mu Dan granules Diabetic peripheral neuropathy(DPN) Animal experiments
  • 相关文献

参考文献7

二级参考文献85

  • 1佟晓哲.糖末宁颗粒剂对糖尿病大鼠坐骨神经组织中cAMP cGMP含量的影响[J].中医药学刊,2006,24(1):137-138. 被引量:8
  • 2宋利格,李颖,周筠,陈亚青,李红,张秀珍.α-硫辛酸对糖尿病周围神经病变的疗效[J].中华内分泌代谢杂志,2007,23(2):166-167. 被引量:92
  • 3张宏睿,林永廉.浅谈中西医结合治疗糖尿病周围神经病变的机理[J].现代中医药,2007,27(4):57-59. 被引量:13
  • 4于世家.糖尿病周围神经病变中西医诊疗规范[C]//全国中西医结合内分泌代谢病学术会议论文汇编.大连,2006.
  • 5llnytska O, Lyzogubov VV, Stevens M J, et al. Poly (ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes, 2006, 55 (6): 1686-1694.
  • 6Gary Pittenger, Aaron Vinik. Nerve Growth Factor and Diabetic Neuropathy. ExpDiabRes, 2003, 4 (4): 271-285.
  • 7Johndon MS, Ryals JM, Wright DE. Diabetes-Induced Chemogenic Hypoalgesia is Paralleld by Attenuated Stimulus-Induced Fos Expression in the Spinal Cord of Diabetic Mice. JPain, 2007, 8 (8): 637-649.
  • 8Calcutt NA, Freshwater JD, Mizisin AE Prevension of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia, 2004, 47 (4): 718-724.
  • 9Pabbidi RM, Yu SQ, Peng S, et al. Influence of TRPVI on diabetes-induced alterations in thermal pain sensitivity. Mol Pain, 2008, 4: 9.
  • 10Dyck PJ, Larson TS, O'Brien PC, et al. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care, 2000, 23 (4) :510-517.

共引文献67

同被引文献194

引证文献16

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部